VILDIABATE M 500
Metformin (500mg)SR, Vildagliptin (50mg)
VILDIABATE M 500 is a combination medication used for managing type 2 diabetes mellitus. It contains Metformin SR (500mg) and Vildagliptin (50mg), offering an effective approach to controlling blood glucose levels.
Composition:
Metformin SR (500mg): A biguanide that reduces liver glucose production, enhances insulin sensitivity, and improves glucose uptake.
Vildagliptin (50mg): A DPP-4 inhibitor that increases incretin hormones, stimulating insulin secretion and decreasing glucagon levels.
Mechanism of Action:
Metformin: Decreases hepatic glucose production and improves insulin sensitivity.
Vildagliptin: Inhibits DPP-4 enzyme, increasing incretin levels, enhancing insulin release, and reducing glucagon secretion.
Indications:
For adults with type 2 diabetes mellitus.
Patients inadequately controlled on metformin alone or on separate tablets of metformin and vildagliptin.
Dosage and Administration:
Recommended Dose: One tablet daily with meals.
Adjustment: Based on glycemic response and tolerance. Follow the doctor\'s prescription. Side Effects:
Gastrointestinal issues: nausea, vomiting, diarrhea.
Hypoglycemia (especially with other antidiabetics).
Upper respiratory tract infections.
Headache, dizziness.
Precautions:
Renal Impairment: Use cautiously with regular monitoring.
Hepatic Impairment: Not recommended for severe liver dysfunction.
Heart Failure: Risk of lactic acidosis with metformin.
Contraindications:
Hypersensitivity to components.
Severe renal or hepatic impairment.
Acute or chronic metabolic acidosis, including diabetic ketoacidosis.
Drug Interactions:
Metformin: Interacts with alcohol, iodinated contrast media, and certain medications like cimetidine.
Vildagliptin: Use with caution with other antidiabetic agents to avoid hypoglycemia.
Conclusion:
VILDIABATE M 500 provides a dual approach to managing type 2 diabetes, combining the benefits of metformin and vildagliptin for better blood sugar control. Use under medical supervision with regular monitoring for optimal results. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma\'s mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.
For further information
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 7877551268, 7849827488
Keywords
healthcare industry
home delivery options
Steris Healthcare Pvt Ltd
Renal Impairment
optimal results
affordable prices
liver glucose production
hepatic glucose production
glucose uptake
separate tablets
extensive product lineup
BUY NOW
diabetic ketoacidosis
Side Effects
lactic acidosis
severe liver dysfunction
other antidiabetic agents
One tablet
other antidiabetics
healthcare products
iodinated contrast media
VILDIABATE M 500 Metformin
Heart Failure
insulin secretion
extensive demands
combination medication
high-quality drugs
advanced treatments
essential health necessities
Nasal Conditions
incretin hormones
effective approach
insulin sensitivity
blood glucose levels
type 2 diabetes mellitus
Severe renal
online pharmacy
regular monitoring
expert professionals
Navi Mumbai
General Medicine
Hepatic Impairment
medical supervision
Metformin SR
insulin release
glucagon levels
blood sugar control
Gastrointestinal issues
broad range
DPP-4 enzyme
diverse needs
rare conditions
DPP-4 inhibitor
medical community
Dental Care
WHO guidelines
incretin levels
glucagon secretion
pharmaceutical industry
chronic metabolic acidosis
Upper respiratory tract infections
dual approach
Drug Interactions
glycemic response
Respiratory Issues
